A detailed history of Bruce G. Allen Investments, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 45 shares of EXAS stock, worth $3,170. This represents 0.0% of its overall portfolio holdings.

Number of Shares
45
Previous 45 -0.0%
Holding current value
$3,170
Previous $1.9 Million 61.23%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$41.33 - $74.26 $413 - $742
-10 Reduced 18.18%
45 $1.9 Million
Q1 2024

Apr 10, 2024

BUY
$56.27 - $73.77 $900 - $1,180
16 Added 41.03%
55 $3.8 Million
Q4 2023

Jan 10, 2024

BUY
$59.06 - $75.72 $2,303 - $2,953
39 New
39 $2.89 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $12.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Bruce G. Allen Investments, LLC Portfolio

Follow Bruce G. Allen Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce G. Allen Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruce G. Allen Investments, LLC with notifications on news.